Clinical trials
Recruiting Scleroderma, Systemic trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 2 |
| 2024 | 6 |
| 2025 | 11 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 30 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fate Therapeutics | 2 |
| Robyn T. Domsic, MD, MPH | 2 |
| The University of Texas Health Science Center, Houston | 2 |
| Yale University | 2 |
| Allogene Therapeutics | 1 |
| Artiva Biotherapeutics, Inc. | 1 |
| AstraZeneca | 1 |
| Boehringer Ingelheim | 1 |
| Boston University | 1 |
| Brigham and Women's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Scleroderma, Systemic | 30 |
| Scleroderma, Diffuse | 14 |
| Lupus Erythematosus, Systemic | 10 |
| Arthritis, Rheumatoid | 8 |
| Myositis | 8 |
| Autoimmune Diseases | 7 |
| Dermatomyositis | 7 |
| Lupus Nephritis | 7 |
| Lung Diseases, Interstitial | 6 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 3 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.